- Current report filing (8-K)
January 28 2009 - 12:40PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE
COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 8, 2009
Hydrogenetics, Inc
(Exact name of registrant as
specified in charter)
Florida
|
|
000-
51036
|
|
65-0712902
|
(State
or jurisdiction of
incorporation
or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.
)
|
4000 Tower Side Terrace, Ste 1903, Miami, FL
|
|
33107
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code:
313-574-1766
4770 Biscayne Boulevard,
Suite 1480, Miami, FL
33179
(Former name
or address if changed since last report)
Check the
appropriate box below if the Form 8-K is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions
(
see
General
Instruction A.2 below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
As used in this report, the terms we, us, our, our company
refer to Hydrogenetics, Inc., a Florida corporation.
On January 16, 2009, the Consulting
Agreement between Mr. Kevin Sepe
and our company was terminated.
On January
8, 2009, the Company removed Mark Balbier as the Investor Relations
contact for our company.
On January
14, 2009, Mr. Halperin was informed that he had no authority to
act in any capacity for our company.
ITEM 9.01.
|
FINANCIAL STATEMENTS AND EXHIBITS.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Marc A.
Walther
Chief Executive Officer
Date: January 28, 2009
Hydrogenetics (CE) (USOTC:HYGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hydrogenetics (CE) (USOTC:HYGN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Hydrogenetics Inc (CE) (OTCMarkets): 0 recent articles
More HYDROGENETICS (OTC) News Articles